As we get ready to enter 2025, the VC landscape is a far cry from the heady days of a few years ago for orthopedic startups navigating the complex funding ecosystem. Ortho startups face unique challenges: long product development cycles, regulatory hurdles, and the need for significant capital to bring cutting-edge medical devices and technologies to market.
It has become clear that many VC-backed funds are grappling with liquidity issues, delayed exits, and shifting market dynamics, which has trickled down to the orthopedic startups.
In this article, we’ll explore how macroeconomic forces,...
